| 000 | 01438 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513165232.0 | ||
| 264 | 0 | _c19990427 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a1420-8008 | ||
| 024 | 7 |
_a10.1159/000017114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aImbimbo, B P | |
| 245 | 0 | 0 |
_aTwo-year treatment of Alzheimer's disease with eptastigmine. The Eptastigmine Study Group. _h[electronic resource] |
| 260 |
_bDementia and geriatric cognitive disorders _c |
||
| 300 |
_a139-47 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aActivities of Daily Living |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aCognition |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhysostigmine _xadverse effects |
| 700 | 1 | _aVerdelli, G | |
| 700 | 1 | _aMartelli, P | |
| 700 | 1 | _aMarchesini, D | |
| 773 | 0 |
_tDementia and geriatric cognitive disorders _gvol. 10 _gno. 2 _gp. 139-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000017114 _zAvailable from publisher's website |
| 999 |
_c9987686 _d9987686 |
||